Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System(®) (RTS(®)) gene switch as gene therapy for the treatment of glioma

The purpose of this study was to determine if localized delivery of IL-12 encoded by a replication-incompetent adenoviral vector engineered to express IL-12 via a RheoSwitch Therapeutic System(®) (RTS(®)) gene switch (Ad-RTS-IL-12) administered intratumorally which is inducibly controlled by the ora...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrett, John A., Cai, Hongliang, Miao, John, Khare, Pranay D., Gonzalez, Paul, Dalsing-Hernandez, Jessica, Sharma, Geeta, Chan, Tim, Cooper, Laurence J.N, Lebel, Francois
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021367/
https://www.ncbi.nlm.nih.gov/pubmed/29755109
http://dx.doi.org/10.1038/s41417-018-0019-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021367/
https://www.ncbi.nlm.nih.gov/pubmed/29755109
http://dx.doi.org/10.1038/s41417-018-0019-0

Ejemplares similares